Research ArticleLaboratory Studies
Internalization of Indium-111 into Human Neuroendocrine Tumor Cells after Incubation with Indium-111-DTPA-D-Phe1-Octreotide
Peter Andersson, Eva Forssell-Aronsson, Viktor Johanson, Bo Wängberg, Ola Nilsson, Martha Fjälling and Håkan Ahlman
Journal of Nuclear Medicine December 1996, 37 (12) 2002-2006;
Peter Andersson
Eva Forssell-Aronsson
Viktor Johanson
Bo Wängberg
Ola Nilsson
Martha Fjälling
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Internalization of Indium-111 into Human Neuroendocrine Tumor Cells after Incubation with Indium-111-DTPA-D-Phe1-Octreotide
Peter Andersson, Eva Forssell-Aronsson, Viktor Johanson, Bo Wängberg, Ola Nilsson, Martha Fjälling, Håkan Ahlman
Journal of Nuclear Medicine Dec 1996, 37 (12) 2002-2006;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Electron- and Positron-Emitting Radiolanthanides for Therapy: Aspects of Dosimetry and Production
- Crucial Role for Somatostatin Receptor Subtype 2 in Determining the Uptake of [111In-DTPA-D-Phe1]Octreotide in Somatostatin Receptor-Positive Organs
- Long-Term Efficacy of High-Activity 111In-Pentetreotide Therapy in Patients with Disseminated Neuroendocrine Tumors
- Peptide Receptor Radionuclide Therapy In Vitro Using [111In-DTPA0]Octreotide
- Tumor Response After [90Y-DOTA0,Tyr3]Octreotide Radionuclide Therapy in a Transplantable Rat Tumor Model Is Dependent on Tumor Size
- Somatostatin Receptors in the Diagnosis and Therapy of Neuroendocrine Tumors